Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases

Isabella Castellano, Anna Sapino, Riccardo Arisio, Giuseppe Viale, Gianni Bussolati, Roberto Bandelloni, Gaetano Barresi, Alessandra Bersiga, Cesare Bordi, Gerardo Botti, Fabia Cosimi, Emanuele D'Amore, Claudio Doglioni, Antonio Marchetti, Oscar Nappi, Francesco Romeo, Massimo Roncalli, Rosa Russo, Alfredo Santinelli, Luigi Giusto Spagnoli & 5 others Francesco Tanda, Paolo Tricomi, Gianpaolo Trentini, Fabrizio Zanconati, Monica Iurlaro

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The aim of the present study was to evaluate the effectiveness of fluorescence in situ hybridisation (FISH), as a screening test, in moderately- (G2) or poorly- (G3) differentiated breast cancers of the ductal (IDC) and lobular (ILC) histotypes and distant metastases. HER2 FISH was performed on 486 G2 and 477 G3 both of IDC and ILC histotypes and in 241 metastases. A significant difference in the HER2 amplification was observed between G2 (14.8%) and G3 (31.9%), with no difference according to the histotype. However, the rate of amplification increased to 36% in the G2/hormone receptor-negative cases as compared to 10.6% in the G2/receptor-positive cases (p

Original languageEnglish
Pages (from-to)1271-1275
Number of pages5
JournalOncology Reports
Volume19
Issue number5
Publication statusPublished - May 2008

Fingerprint

Fluorescence In Situ Hybridization
Breast Neoplasms
Neoplasm Metastasis
Hormones

Keywords

  • Breast
  • Cancer
  • Effectiveness
  • Fluorescence in situ hybridisation
  • HER2
  • Metastases

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases. / Castellano, Isabella; Sapino, Anna; Arisio, Riccardo; Viale, Giuseppe; Bussolati, Gianni; Bandelloni, Roberto; Barresi, Gaetano; Bersiga, Alessandra; Bordi, Cesare; Botti, Gerardo; Cosimi, Fabia; D'Amore, Emanuele; Doglioni, Claudio; Marchetti, Antonio; Nappi, Oscar; Romeo, Francesco; Roncalli, Massimo; Russo, Rosa; Santinelli, Alfredo; Spagnoli, Luigi Giusto; Tanda, Francesco; Tricomi, Paolo; Trentini, Gianpaolo; Zanconati, Fabrizio; Iurlaro, Monica.

In: Oncology Reports, Vol. 19, No. 5, 05.2008, p. 1271-1275.

Research output: Contribution to journalArticle

Castellano, I, Sapino, A, Arisio, R, Viale, G, Bussolati, G, Bandelloni, R, Barresi, G, Bersiga, A, Bordi, C, Botti, G, Cosimi, F, D'Amore, E, Doglioni, C, Marchetti, A, Nappi, O, Romeo, F, Roncalli, M, Russo, R, Santinelli, A, Spagnoli, LG, Tanda, F, Tricomi, P, Trentini, G, Zanconati, F & Iurlaro, M 2008, 'Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases', Oncology Reports, vol. 19, no. 5, pp. 1271-1275.
Castellano, Isabella ; Sapino, Anna ; Arisio, Riccardo ; Viale, Giuseppe ; Bussolati, Gianni ; Bandelloni, Roberto ; Barresi, Gaetano ; Bersiga, Alessandra ; Bordi, Cesare ; Botti, Gerardo ; Cosimi, Fabia ; D'Amore, Emanuele ; Doglioni, Claudio ; Marchetti, Antonio ; Nappi, Oscar ; Romeo, Francesco ; Roncalli, Massimo ; Russo, Rosa ; Santinelli, Alfredo ; Spagnoli, Luigi Giusto ; Tanda, Francesco ; Tricomi, Paolo ; Trentini, Gianpaolo ; Zanconati, Fabrizio ; Iurlaro, Monica. / Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases. In: Oncology Reports. 2008 ; Vol. 19, No. 5. pp. 1271-1275.
@article{0ab7807e83a648f788d028601eea31ee,
title = "Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases",
abstract = "The aim of the present study was to evaluate the effectiveness of fluorescence in situ hybridisation (FISH), as a screening test, in moderately- (G2) or poorly- (G3) differentiated breast cancers of the ductal (IDC) and lobular (ILC) histotypes and distant metastases. HER2 FISH was performed on 486 G2 and 477 G3 both of IDC and ILC histotypes and in 241 metastases. A significant difference in the HER2 amplification was observed between G2 (14.8{\%}) and G3 (31.9{\%}), with no difference according to the histotype. However, the rate of amplification increased to 36{\%} in the G2/hormone receptor-negative cases as compared to 10.6{\%} in the G2/receptor-positive cases (p",
keywords = "Breast, Cancer, Effectiveness, Fluorescence in situ hybridisation, HER2, Metastases",
author = "Isabella Castellano and Anna Sapino and Riccardo Arisio and Giuseppe Viale and Gianni Bussolati and Roberto Bandelloni and Gaetano Barresi and Alessandra Bersiga and Cesare Bordi and Gerardo Botti and Fabia Cosimi and Emanuele D'Amore and Claudio Doglioni and Antonio Marchetti and Oscar Nappi and Francesco Romeo and Massimo Roncalli and Rosa Russo and Alfredo Santinelli and Spagnoli, {Luigi Giusto} and Francesco Tanda and Paolo Tricomi and Gianpaolo Trentini and Fabrizio Zanconati and Monica Iurlaro",
year = "2008",
month = "5",
language = "English",
volume = "19",
pages = "1271--1275",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Fluorescent in situ hybridization as a screening test for HER2 amplification in G2 and G3 breast cancers of lobular and ductal histotype and metastases

AU - Castellano, Isabella

AU - Sapino, Anna

AU - Arisio, Riccardo

AU - Viale, Giuseppe

AU - Bussolati, Gianni

AU - Bandelloni, Roberto

AU - Barresi, Gaetano

AU - Bersiga, Alessandra

AU - Bordi, Cesare

AU - Botti, Gerardo

AU - Cosimi, Fabia

AU - D'Amore, Emanuele

AU - Doglioni, Claudio

AU - Marchetti, Antonio

AU - Nappi, Oscar

AU - Romeo, Francesco

AU - Roncalli, Massimo

AU - Russo, Rosa

AU - Santinelli, Alfredo

AU - Spagnoli, Luigi Giusto

AU - Tanda, Francesco

AU - Tricomi, Paolo

AU - Trentini, Gianpaolo

AU - Zanconati, Fabrizio

AU - Iurlaro, Monica

PY - 2008/5

Y1 - 2008/5

N2 - The aim of the present study was to evaluate the effectiveness of fluorescence in situ hybridisation (FISH), as a screening test, in moderately- (G2) or poorly- (G3) differentiated breast cancers of the ductal (IDC) and lobular (ILC) histotypes and distant metastases. HER2 FISH was performed on 486 G2 and 477 G3 both of IDC and ILC histotypes and in 241 metastases. A significant difference in the HER2 amplification was observed between G2 (14.8%) and G3 (31.9%), with no difference according to the histotype. However, the rate of amplification increased to 36% in the G2/hormone receptor-negative cases as compared to 10.6% in the G2/receptor-positive cases (p

AB - The aim of the present study was to evaluate the effectiveness of fluorescence in situ hybridisation (FISH), as a screening test, in moderately- (G2) or poorly- (G3) differentiated breast cancers of the ductal (IDC) and lobular (ILC) histotypes and distant metastases. HER2 FISH was performed on 486 G2 and 477 G3 both of IDC and ILC histotypes and in 241 metastases. A significant difference in the HER2 amplification was observed between G2 (14.8%) and G3 (31.9%), with no difference according to the histotype. However, the rate of amplification increased to 36% in the G2/hormone receptor-negative cases as compared to 10.6% in the G2/receptor-positive cases (p

KW - Breast

KW - Cancer

KW - Effectiveness

KW - Fluorescence in situ hybridisation

KW - HER2

KW - Metastases

UR - http://www.scopus.com/inward/record.url?scp=47549084286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47549084286&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 1271

EP - 1275

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 5

ER -